药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Amifostine
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Romidepsin.
Amifostine
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Romidepsin.
Amifostine
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Romidepsin.
Amifostine
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Romidepsin.
Amifostine
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Romidepsin.
Amifostine
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Romidepsin.
Amifostine
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Romidepsin.
Amifostine
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Romidepsin.
Amifostine
Bupranolol
The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Romidepsin.
Amifostine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Romidepsin.
Amifostine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Romidepsin.
Amifostine
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Romidepsin.
Amifostine
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Romidepsin.
Amifostine
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Romidepsin.
Amifostine
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Romidepsin.
Amifostine
Mepyramine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Romidepsin.
Amifostine
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Romidepsin.
Amifostine
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Romidepsin.
Amifostine
Levocetirizine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Romidepsin.
Amifostine
Vernakalant
The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Romidepsin.